Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Goodwill & Intangibles: 2009-2025

Historic Goodwill & Intangibles for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $18.1 million.

  • Lifecore Biomedical's Goodwill & Intangibles changed negligibly% to $18.1 million in Q2 2025 from the same period last year, while for May 2025 it was $18.1 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $18.1 million for FY2025, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Goodwill & Intangibles is $18.1 million, which was down 0.00% from $18.1 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Goodwill & Intangibles peaked at $18.1 million during FY2022, and registered a low of $18.1 million during FY2021.
  • In the last 3 years, Lifecore Biomedical's Goodwill & Intangibles had a median value of $18.1 million in 2025 and averaged $18.1 million.
  • Per our database at Business Quant, Lifecore Biomedical's Goodwill & Intangibles plummeted by 69.48% in 2021 and then increased by 0.11% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Goodwill & Intangibles (Yearly) stood at $18.1 million in 2021, then grew by 0.11% to $18.1 million in 2022, then remained steady at $18.1 million in 2023, then declined by 0.10% to $18.1 million in 2024, then remained steady at $18.1 million in 2025.